Brady Garabato

Brady Garabato has worked in various scientific roles since 2013. Brady obtained their PhD from the University of Louisville in 2013, then worked as a Postdoctoral Researcher at the Istituto Italiano di Tecnologia from 2018 to 2020. In 2020, they began working as a Principal Scientist at Novartis Institutes for BioMedical Research (NIBR), and in 2021 they were promoted to Senior Scientist at Redesign Science.

Brady Garabato completed a Doctor of Philosophy (PhD) in Computational Chemistry from the University of Louisville School of Medicine between 2013 and 2018.